NIR Laser Helps Identify Heart Attack and Stroke Risk
|
By HospiMedica International staff writers Posted on 29 Aug 2017 |

Image: An NIR autofluorescence of heme products can detect bleeding plaques (Photo courtesy of Karlheinz Peter).
A new study suggests that near-infrared (NIR) autofluorescence imaging could aid early detection of high-risk atherosclerotic plaques and intra-plaque hemorrhage.
In a study at Monash University (Melbourne, Australia), the University of Warwick (Coventry, United Kingdom), and other institutions, researchers found that heme degradation products--particularly bilirubin--can be detected by increasing the wavelength of infrared (IR) illumination--currently used to detect fatty deposit build-up in arteries--to NIR wavelengths. In a mouse model, fluorescence emission computed tomography (CT) detected the NIR autofluorescence of heme products and intra-plaque bleeding via Raman spectroscopy.
Heme by-products, especially bilirubin, were only observed in unstable plaques with internal bleeding, and were not observed in the more stable fatty deposits. Similar results were seen when the researchers examined human carotid endarterectomy (CEA) specimens collected from patients who presented to the Alfred Hospital (Melbourne, Australia). According to the researchers, the improved selectivity for high-risk atherosclerotic deposits could help doctors to identify the most at-risk patients. The study was published on July 13, 2017, in Nature Communications.
“We realized when we shine a light in the near-infrared wavelength range, that this light is reflected at a certain wavelength. So in a way we can use laser light to shine up the plaques that are unstable, and it's very characteristic,” said senior author Karlheinz Peter, MD, of Monash University. “After further investigation with clinical trials, this method of imaging technique could be used to assess unstable fatty arterial plaques, and could be used to monitor the effectiveness of the drugs used to prevent heart attacks or strokes.”
Bilirubin is the yellow pigmented breakdown product of normal heme catabolism, caused by the body's clearance of aged red blood cells (RBCs), which contain hemoglobin. It is excreted in bile and urine, and elevated levels may indicate certain diseases. Bilirubin is responsible for the yellow color of bruises and the yellow discoloration in jaundice. It is also responsible for the brown color of feces, via its conversion to stercobilin, and the background straw-yellow color of urine via its breakdown product, urobilin.
Related Links:
Monash University
University of Warwick
In a study at Monash University (Melbourne, Australia), the University of Warwick (Coventry, United Kingdom), and other institutions, researchers found that heme degradation products--particularly bilirubin--can be detected by increasing the wavelength of infrared (IR) illumination--currently used to detect fatty deposit build-up in arteries--to NIR wavelengths. In a mouse model, fluorescence emission computed tomography (CT) detected the NIR autofluorescence of heme products and intra-plaque bleeding via Raman spectroscopy.
Heme by-products, especially bilirubin, were only observed in unstable plaques with internal bleeding, and were not observed in the more stable fatty deposits. Similar results were seen when the researchers examined human carotid endarterectomy (CEA) specimens collected from patients who presented to the Alfred Hospital (Melbourne, Australia). According to the researchers, the improved selectivity for high-risk atherosclerotic deposits could help doctors to identify the most at-risk patients. The study was published on July 13, 2017, in Nature Communications.
“We realized when we shine a light in the near-infrared wavelength range, that this light is reflected at a certain wavelength. So in a way we can use laser light to shine up the plaques that are unstable, and it's very characteristic,” said senior author Karlheinz Peter, MD, of Monash University. “After further investigation with clinical trials, this method of imaging technique could be used to assess unstable fatty arterial plaques, and could be used to monitor the effectiveness of the drugs used to prevent heart attacks or strokes.”
Bilirubin is the yellow pigmented breakdown product of normal heme catabolism, caused by the body's clearance of aged red blood cells (RBCs), which contain hemoglobin. It is excreted in bile and urine, and elevated levels may indicate certain diseases. Bilirubin is responsible for the yellow color of bruises and the yellow discoloration in jaundice. It is also responsible for the brown color of feces, via its conversion to stercobilin, and the background straw-yellow color of urine via its breakdown product, urobilin.
Related Links:
Monash University
University of Warwick
Latest Critical Care News
- Eye Imaging AI Identifies Elevated Cardiovascular Risk
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
Spinal and orthopedic fusion procedures often require bone graft materials that handle predictably and support bone formation. Surgeons face added complexity in difficult anatomy and challenging fusion environments.... Read more
Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
Acute pulmonary embolism can cause rapid hemodynamic deterioration and early death in hospitalized and emergency patients. Systemic thrombolysis can dissolve clots but is limited by a high risk of major... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







